A multi-centerdouble-blind parallel-group placebo-controlled study of the efficacy and safety of teriflulomide in patients with relapsing Multiple Sclerosis who are treated with interferon-beta.
Laufzeit: 01.01.2011 - 31.12.2014
Kurzfassung
MR Imaging enrolled in the above mentioned, doubleblind, placebo-controlled clinical trail. The focus is the effectivity and security of Teriflunomid in comparison with the therapy with Interferon-beta in multiple sclerosis.
Beteiligte Einrichtungen
